ArticleAnalytical chemistry2025
Analysis of Drugs in Whole Blood by Paper Spray Mass Spectrometry with Integrated Solid-Phase Extraction.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Portable origami paper-based photoacoustic-photothermal dual-mode device for on-site antioxidants detection.Mikrochimica acta · 2026Article
- Microfluidic Paper-Based Devices at the Edge of Real Samples: Fabrication Limits, Hybrid Detection, and Perspectives.Micromachines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The continued rise in overdoses, driven by fentanyl and novel psychoactive substances (NPS), underscores the need for improved methods for drug screening. Traditional analytical techniques involving chromatography can be time-consuming and require sample preparation. Paper spray mass spectrometry (PS-MS) can rapidly detect analytes from complex matrices. However, challenges such as matrix effects can lead to higher detection limits, prompting improvements aimed at preconcentrating or cleaning up samples. While most methods focus on plasma analysis, there is a need to further simplify sample preparation, particularly for whole blood. Here, we report on three-dimensional (3D)-printed devices that preconcentrate drugs from whole blood for PS-MS analysis. An uncontrolled amount of blood was added to the blood reservoir part of the cartridge. The capillary fills and then rotates to sit on top of the SPE column. The blood wicks through the SPE to the waste pad, and the sample is left to dry until analysis. The dry SPE holder is "snapped" in the paper spray cartridge. A variety of parameters were optimized to improve manufacturing and the performance of the device, including waste pad substrates, SPE sorbents, and binders; the size of the SPE compartment; the amount of SPE; a water wash step; and blood volume. Performance was tested with 21 different drugs including opioids like fentanyl and isotonitazene, cathinones, designer and prescription benzodiazepines, cocaine, methamphetamine, and synthetic cannabinoids. Dried blood samples were found to be stable for at least 14 days. The detection limits were at single digit or subng/mL levels or lower for all analytes for 70 μL blood sample, with a median decrease of 9-fold compared to paper spray without SPE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.